STOCK TITAN

Vaxart (NASDAQ: VXRT) CEO has shares withheld to cover RSU taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Vaxart, Inc. President and CEO Steven Lo reported a tax-related share disposition tied to restricted stock units (RSUs). On March 24, 2026, 126,028 shares of common stock were withheld by the company to satisfy income tax withholding and remittance obligations upon RSU vesting, rather than sold in the open market.

Following this withholding, Lo directly holds 2,485,606 shares of Vaxart common stock and indirectly holds 100,000 shares through the Lo Family Trust. The filing reflects routine equity compensation and associated tax treatment rather than a discretionary buy or sell decision.

Positive

  • None.

Negative

  • None.
Insider Lo Steven
Role President, Chief Exec Officer
Type Security Shares Price Value
Tax Withholding Common Stock 126,028 $0.694 $87K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 2,485,606 shares (Direct); Common Stock — 100,000 shares (Indirect, By the Lo Family Trust)
Footnotes (1)
  1. [object Object]
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lo Steven

(Last)(First)(Middle)
C/O VAXART, INC.
170 HARBOR WAY, SUITE 300

(Street)
SOUTH SAN FRANCISCO CALIFORNIA 94080

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Vaxart, Inc. [ VXRT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President, Chief Exec Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/24/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/24/2026F126,028(1)D$0.6942,485,606D
Common Stock100,000IBy the Lo Family Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 24, 2026.
/s/ Edward Berg, Attorney-in-Fact03/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Vaxart (VXRT) CEO Steven Lo report in this Form 4?

Steven Lo reported that 126,028 Vaxart common shares were withheld by the company to cover income tax obligations on vested RSUs. This is a non-market, tax-withholding disposition, not an open-market sale or purchase of shares by the CEO.

How many Vaxart (VXRT) shares were withheld for taxes from Steven Lo?

A total of 126,028 Vaxart common shares were withheld to satisfy the issuer’s income tax withholding and remittance obligations. The withholding occurred in connection with the net settlement of RSUs that vested as of March 24, 2026, according to the filing footnote.

How many Vaxart (VXRT) shares does Steven Lo hold after this Form 4 event?

After the tax withholding, Steven Lo directly holds 2,485,606 Vaxart common shares. In addition, he has an indirect holding of 100,000 shares through the Lo Family Trust, as reported in the Form 4 ownership table.

Was the Vaxart (VXRT) Form 4 transaction an open-market sale by Steven Lo?

The filing indicates it was not an open-market sale. The 126,028 shares were withheld by Vaxart to satisfy tax obligations on vested RSUs, coded as a tax-withholding disposition, which is part of routine equity compensation administration.

What role does the Lo Family Trust play in Steven Lo’s Vaxart (VXRT) holdings?

The Form 4 shows an indirect ownership entry of 100,000 Vaxart common shares held "By the Lo Family Trust." This reflects shares attributed to Steven Lo through the trust, separate from his 2,485,606 directly held shares reported in the filing.
Vaxart Inc

OTC:VXRT

View VXRT Stock Overview

VXRT Rankings

VXRT Latest News

VXRT Latest SEC Filings

VXRT Stock Data

103.16M
225.15M
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO